Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Immunomodulation
Locations
1
Sweden
Karolinska Institutet
Stockholm, Sweden
Start Date
January 1, 2024
Primary Completion Date
December 31, 2030
Completion Date
December 31, 2031
Last Updated
February 8, 2024
NCT06948110
NCT00001467
NCT07071623
NCT03394053
NCT06342713
NCT07115901
Lead Sponsor
Karolinska Institutet
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions